About this trial
This randomized controlled trial aims to evaluate the effectiveness of topical paraffin oil application in preventing tourniquet-related skin lesions in patients undergoing upper extremity surgery. Pneumatic tourniquets are commonly used to provide a bloodless surgical field; however, they may cause skin complications such as erythema, edema, abrasions, blisters, and burns.
In this study, adult patients undergoing elective upper extremity surgery will be randomly assigned to either an intervention group receiving topical paraffin oil application in addition to routine protective dressing or a control group receiving routine care only. Skin integrity will be assessed immediately after tourniquet removal and at 30 and 60 minutes postoperatively using standardized skin assessment criteria.
The findings of this study are expected to contribute to the development of effective, simple, and cost-efficient strategies to prevent tourniquet-related skin complications and improve patient safety and postoperative comfort.
Eligibility criteria
Qualifiers
Age ≥18 years
Patients scheduled for elective upper extremity surgery requiring pneumatic tourniquet application
ASA physical status I-III
Body mass index (BMI) <30 kg/m²
Disqualifiers
Age <18 years
Known dermatological disease or existing skin lesion at the tourniquet application site
Allergy or sensitivity to paraffin oil or related substances
Severe systemic disease (ASA IV or higher)
Trial design
Treatments tested in this trial
- Paraffin Oil
Treatment groups
Sponsors and collaborators
Istanbul Medipol University Hospital
Lead sponsor
Kartal Dr. Lütfi Kirdar City Hospital
Collaborator
Medipol University
Collaborator